| 注册
首页|期刊导航|右江医学|三基序家族蛋白在肝细胞癌中的研究进展

三基序家族蛋白在肝细胞癌中的研究进展

刘国满 韦花媚 浦涧

右江医学2023,Vol.51Issue(12):1057-1062,6.
右江医学2023,Vol.51Issue(12):1057-1062,6.DOI:10.3969/j.issn.1003-1383.2023.12.001

三基序家族蛋白在肝细胞癌中的研究进展

Research progress of tripartite motif in hepatocellular carcinoma

刘国满 1韦花媚 2浦涧3

作者信息

  • 1. 右江民族医学院附属医院肝胆外科,广西百色 533000||右江民族医学院研究生学院,广西百色 533000
  • 2. 右江民族医学院附属医院临床病理与诊断研究中心,广西百色 533000
  • 3. 右江民族医学院附属医院肝胆外科,广西百色 533000
  • 折叠

摘要

Abstract

Hepatocellular carcinoma(HCC)has the characteristics of insidious disease,easy metastasis,insensitivity to chemo-therapy,and extremely poor prognosis,which poses great challenges to clinical diagnosis and treatment.Therefore,it is very important to explore molecular markers and therapeutic targets for more accurate diagnosis of HCC.Tripartite motif(TRIM)is a kind of protein with E3 ubiquitin ligase activity.At present,it is generally believed that TRIM plays a key role in the process of the proliferation,me-tastasis,and drug resistance of HCC,and its mechanism of action may involve multiple signaling pathways,which is expected to be-come a new target for HCC treatment.This article provides a review of the research progress of TRIM in HCC,providing a literature reference for the in-depth study of TRIM in HCC.

关键词

三基序家族蛋白/肝细胞癌/信号通路

Key words

tripartite motif(TRIM)/hepatocellular carcinoma(HCC)/signaling pathway

分类

临床医学

引用本文复制引用

刘国满,韦花媚,浦涧..三基序家族蛋白在肝细胞癌中的研究进展[J].右江医学,2023,51(12):1057-1062,6.

基金项目

国家自然科学基金(82260593) (82260593)

右江医学

1003-1383

访问量0
|
下载量0
段落导航相关论文